ELI LILLY & Co
LLYNYSECIK 59478HealthcareFiscal year ends Dec 31
Latest reported revenue, Q3 FY2026$24.40bnRevenue, Q3 FY2026, three months to 2026-09-30$24.40bn. XBRL concept
us-gaap:Revenues. 10-Q filed 2026-10-29, accession 0000059478-26-000108.Report this figureThree months to Sep 30, 2026, from the 10-Q filed Oct 29, 2026.Latest quarter: Q3 FY2026
Three months to Sep 30, 2026, against the same quarter a year earlier.
- Revenue$24.40bnRevenue, Q3 FY2026, three months to 2026-09-30$24.40bn. XBRL concept
us-gaap:Revenues. 10-Q filed 2026-10-29, accession 0000059478-26-000108.Report this figure+38.6% on a year earlier - Gross marginnot reported (Gross profit not reported)No year-earlier figure to compare
- Operating marginnot reported (Operating income not reported)No year-earlier figure to compare
- Net margin26.4%Net margin, Q3 FY2026, three months to 2026-09-30. net income / revenueNet income: $6.45bn. XBRL concept
us-gaap:NetIncomeLoss. 10-Q filed 2026-10-29, accession 0000059478-26-000108.Revenue: $24.40bn. XBRL conceptus-gaap:Revenues. 10-Q filed 2026-10-29, accession 0000059478-26-000108.Report this figure−5.3 pts on a year earlier - Diluted EPS$7.22Diluted EPS, Q3 FY2026, three months to 2026-09-30$7.22 per share. XBRL concept
us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-10-29, accession 0000059478-26-000108.Report this figure+16.3% on a year earlier - Free cash flownot reported (Capital expenditure not reported)No year-earlier figure to compare
Last eight quarters
Full statements| Line item | Unit | Q4 FY20242024-12-31 | Q1 FY20252025-03-31 | Q2 FY20252025-06-30 | Q3 FY20252025-09-30 | Q4 FY20252025-12-31 | Q1 FY20262026-03-31 | Q2 FY20262026-06-30 | Q3 FY20262026-09-30 | Shape over the periods |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $bn | 13.5Revenue, Q4 FY2024, three months to 2024-12-31$13.53bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-12, accession 0000059478-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure | 12.7Revenue, Q1 FY2025, three months to 2025-03-31$12.73bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-04-30, accession 0000059478-26-000045.Report this figure | 15.6Revenue, Q2 FY2025, three months to 2025-06-30$15.56bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-05, accession 0000059478-26-000081.Report this figure | 17.6Revenue, Q3 FY2025, three months to 2025-09-30$17.60bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-10-29, accession 0000059478-26-000108.Report this figure | 19.3Revenue, Q4 FY2025, three months to 2025-12-31$19.29bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-12, accession 0000059478-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure | 19.8Revenue, Q1 FY2026, three months to 2026-03-31$19.80bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-04-30, accession 0000059478-26-000045.Report this figure | 23.0Revenue, Q2 FY2026, three months to 2026-06-30$22.97bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-05, accession 0000059478-26-000081.Report this figure | 24.4Revenue, Q3 FY2026, three months to 2026-09-30$24.40bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-10-29, accession 0000059478-26-000108.Report this figure | |
| Gross margin | % | not reported (Gross profit not reported) | not reported (Gross profit not reported) | not reported (Gross profit not reported) | not reported (Gross profit not reported) | not reported (Gross profit not reported) | not reported (Gross profit not reported) | not reported (Gross profit not reported) | not reported (Gross profit not reported) | |
| Operating margin | % | not reported (Operating income not reported) | not reported (Operating income not reported) | not reported (Operating income not reported) | not reported (Operating income not reported) | not reported (Operating income not reported) | not reported (Operating income not reported) | not reported (Operating income not reported) | not reported (Operating income not reported) | |
| Net margin | % | 32.6%Net margin, Q4 FY2024, three months to 2024-12-31. net income / revenueNet income: $4.41bn. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-12, accession 0000059478-26-000013. Derived: 12-month figure less the 9-month figure.Revenue: $13.53bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-12, accession 0000059478-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure | 21.7%Net margin, Q1 FY2025, three months to 2025-03-31. net income / revenueNet income: $2.76bn. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-04-30, accession 0000059478-26-000045.Revenue: $12.73bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-04-30, accession 0000059478-26-000045.Report this figure | 36.4%Net margin, Q2 FY2025, three months to 2025-06-30. net income / revenueNet income: $5.66bn. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0000059478-26-000081.Revenue: $15.56bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-05, accession 0000059478-26-000081.Report this figure | 31.7%Net margin, Q3 FY2025, three months to 2025-09-30. net income / revenueNet income: $5.58bn. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-29, accession 0000059478-26-000108.Revenue: $17.60bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-10-29, accession 0000059478-26-000108.Report this figure | 34.4%Net margin, Q4 FY2025, three months to 2025-12-31. net income / revenueNet income: $6.64bn. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-12, accession 0000059478-26-000013. Derived: 12-month figure less the 9-month figure.Revenue: $19.29bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-12, accession 0000059478-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure | 37.4%Net margin, Q1 FY2026, three months to 2026-03-31. net income / revenueNet income: $7.40bn. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-04-30, accession 0000059478-26-000045.Revenue: $19.80bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-04-30, accession 0000059478-26-000045.Report this figure | 30.9%Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: $7.09bn. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0000059478-26-000081.Revenue: $22.97bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-05, accession 0000059478-26-000081.Report this figure | 26.4%Net margin, Q3 FY2026, three months to 2026-09-30. net income / revenueNet income: $6.45bn. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-29, accession 0000059478-26-000108.Revenue: $24.40bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-10-29, accession 0000059478-26-000108.Report this figure | |
| Diluted EPS | $ per share | not reported (Diluted EPS not reported) | 3.06Diluted EPS, Q1 FY2025, three months to 2025-03-31$3.06 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-30, accession 0000059478-26-000045.Report this figure | 6.29Diluted EPS, Q2 FY2025, three months to 2025-06-30$6.29 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0000059478-26-000081.Report this figure | 6.21Diluted EPS, Q3 FY2025, three months to 2025-09-30$6.21 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-10-29, accession 0000059478-26-000108.Report this figure | not reported (Diluted EPS not reported) | 8.26Diluted EPS, Q1 FY2026, three months to 2026-03-31$8.26 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-30, accession 0000059478-26-000045.Report this figure | 7.94Diluted EPS, Q2 FY2026, three months to 2026-06-30$7.94 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0000059478-26-000081.Report this figure | 7.22Diluted EPS, Q3 FY2026, three months to 2026-09-30$7.22 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-10-29, accession 0000059478-26-000108.Report this figure | |
| Free cash flow | $bn | not reported (Capital expenditure not reported) | not reported (Capital expenditure not reported) | not reported (Capital expenditure not reported) | not reported (Capital expenditure not reported) | not reported (Capital expenditure not reported) | not reported (Capital expenditure not reported) | not reported (Capital expenditure not reported) | not reported (Capital expenditure not reported) |
Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.
Last five fiscal years
| Line item | Unit | FY20212021-12-31 | FY20222022-12-31 | FY20232023-12-31 | FY20242024-12-31 | FY20252025-12-31 | Shape over the periods |
|---|---|---|---|---|---|---|---|
| Revenue | $bn | 28.3Revenue, FY2021, twelve months to 2021-12-31$28.32bn. XBRL concept us-gaap:Revenues. 10-K filed 2024-02-21, accession 0000059478-24-000065.Report this figure | 28.5Revenue, FY2022, twelve months to 2022-12-31$28.54bn. XBRL concept us-gaap:Revenues. 10-K filed 2025-02-19, accession 0000059478-25-000067.Report this figure | 34.1Revenue, FY2023, twelve months to 2023-12-31$34.12bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-12, accession 0000059478-26-000013.Report this figure | 45.0Revenue, FY2024, twelve months to 2024-12-31$45.04bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-12, accession 0000059478-26-000013.Report this figure | 65.2Revenue, FY2025, twelve months to 2025-12-31$65.18bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-12, accession 0000059478-26-000013.Report this figure | |
| Gross margin | % | not reported (Gross profit not reported) | not reported (Gross profit not reported) | not reported (Gross profit not reported) | not reported (Gross profit not reported) | not reported (Gross profit not reported) | |
| Operating margin | % | not reported (Operating income not reported) | not reported (Operating income not reported) | not reported (Operating income not reported) | not reported (Operating income not reported) | not reported (Operating income not reported) | |
| Net margin | % | 19.7%Net margin, FY2021, twelve months to 2021-12-31. net income / revenueNet income: $5.58bn. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2024-02-21, accession 0000059478-24-000065.Revenue: $28.32bn. XBRL concept us-gaap:Revenues. 10-K filed 2024-02-21, accession 0000059478-24-000065.Report this figure | 21.9%Net margin, FY2022, twelve months to 2022-12-31. net income / revenueNet income: $6.24bn. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-02-19, accession 0000059478-25-000067.Revenue: $28.54bn. XBRL concept us-gaap:Revenues. 10-K filed 2025-02-19, accession 0000059478-25-000067.Report this figure | 15.4%Net margin, FY2023, twelve months to 2023-12-31. net income / revenueNet income: $5.24bn. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-12, accession 0000059478-26-000013.Revenue: $34.12bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-12, accession 0000059478-26-000013.Report this figure | 23.5%Net margin, FY2024, twelve months to 2024-12-31. net income / revenueNet income: $10.59bn. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-12, accession 0000059478-26-000013.Revenue: $45.04bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-12, accession 0000059478-26-000013.Report this figure | 31.7%Net margin, FY2025, twelve months to 2025-12-31. net income / revenueNet income: $20.64bn. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-12, accession 0000059478-26-000013.Revenue: $65.18bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-12, accession 0000059478-26-000013.Report this figure | |
| Diluted EPS | $ per share | 6.12Diluted EPS, FY2021, twelve months to 2021-12-31$6.12 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2024-02-21, accession 0000059478-24-000065.Report this figure | 6.90Diluted EPS, FY2022, twelve months to 2022-12-31$6.90 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-02-19, accession 0000059478-25-000067.Report this figure | 5.80Diluted EPS, FY2023, twelve months to 2023-12-31$5.80 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-12, accession 0000059478-26-000013.Report this figure | 11.71Diluted EPS, FY2024, twelve months to 2024-12-31$11.71 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-12, accession 0000059478-26-000013.Report this figure | 22.95Diluted EPS, FY2025, twelve months to 2025-12-31$22.95 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-12, accession 0000059478-26-000013.Report this figure | |
| Free cash flow | $bn | not reported (Capital expenditure not reported) | not reported (Capital expenditure not reported) | not reported (Capital expenditure not reported) | not reported (Capital expenditure not reported) | not reported (Capital expenditure not reported) |
Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.
Insider purchases and sales
All insider transactionsThe last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.
No open-market purchases or sales by insiders are in coverage from Nov 2024 to Oct 2026.
No open-market purchases or sales by insiders are in coverage for this company.
Funds that report holding it
All fundsFrom each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.
| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|
| LILLY ENDOWMENT INC | 2026-06-30 | $108.40bn | 90,376,978 | Reduced−1,520,000 | |
| BlackRock, Inc. | 2026-06-30 | $81.01bn | 67,540,400 | Added+1,159,558 | |
| VANGUARD CAPITAL MANAGEMENT LLC | 2026-06-30 | $64.20bn | 53,528,868 | Added+167,094 | |
| PNC Financial Services Group, Inc. | 2026-06-30 | $61.56bn | 51,322,720 | Reduced−6,188 | |
| STATE STREET CORP | 2026-06-30 | $43.44bn | 36,215,754 | Added+605,752 | |
| FMR LLC | 2026-06-30 | $34.14bn | 28,462,475 | Added+2,121,444 | |
| Capital Research Global Investors | 2026-06-30 | $25.04bn | 20,873,140 | Reduced−3,759,507 | |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 2026-06-30 | $25.02bn | 20,859,217 | Reduced−117,810 | |
| GEODE CAPITAL MANAGEMENT, LLC | 2026-06-30 | $24.28bn | 20,310,858 | Added+118,994 | |
| MORGAN STANLEY | 2026-06-30 | $19.46bn | 16,226,398 | Added+788,940 |
Recent filings
All 2,828 filingsReports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2911:35 ET | 10-Q | Quarterly reportPeriod 2026-09-30 | 0000059478-26-000108 |
| 2026-10-2907:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000059478-26-000104 |
| 2026-10-1616:19 ET | SCHEDULE 13D | Ownership report, active investor | 0000059478-26-000095 |
| 2026-08-0514:40 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0000059478-26-000081 |
| 2026-08-0507:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000059478-26-000077 |
| 2026-07-3016:39 ET | SCHEDULE 13D | Ownership report, active investor | 0000059478-26-000072 |
| 2026-05-2016:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-232707 |
| 2026-05-0716:41 ET | 8-K | 5.07 Shareholder vote results | 0000059478-26-000048 |
| 2026-04-3011:25 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0000059478-26-000045 |
| 2026-04-3007:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000059478-26-000043 |
Latest annual report
Form 10-K for the fiscal year ended Dec 31, 2025Filed Feb 12, 2026. Its page lists the documents and the extracted sections, such as Business and Risk factors.
Forecast league
Q3 FY2026, the quarter ended 2026-09-30, has been scored from the reported figures.See the target
About the filer
- CIK
- 59478
- Tickers
- LLY
- Exchange
- NYSE
- SIC code
- 2834 Pharmaceutical Preparations
- Sector
- Healthcare
- Fiscal year ends
- Dec 31
- Incorporated in
- IN
- Filer category
- Large accelerated filer
- Former names
- LILLY ELI & CO (to 2019-10-25); LILLY ELI & CO ET AL (to 1994-10-14)
Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 12:09 ET. Listed shows no prices and gives no investment advice.